Health Care & Life Sciences » Pharmaceuticals | HanAll Biopharma Co. Ltd.

HanAll Biopharma Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
21,499
12,658
7,077
2,026
5,813
3,300
Depreciation, Depletion & Amortization
1,952
2,260
2,317
2,235
2,162
1,989
Other Funds
3,000
-
-
-
-
8,870
Funds from Operations
8,031
3,358
2,381
6,440
9,380
14,159
Changes in Working Capital
251
6,876
1,927
2,489
32,759
17,154
Net Operating Cash Flow
7,780
3,518
454
3,950
42,139
2,994
Capital Expenditures
6,564
3,600
3,347
4,032
2,208
Sale of Fixed Assets & Businesses
49
5
6
226
310
Purchase/Sale of Investments
17,576
1,761
33,141
6,998
8,154
Net Investing Cash Flow
11,088
1,835
36,316
10,803
10,052
Issuance/Reduction of Debt, Net
11,104
2,914
20,194
-
-
Net Financing Cash Flow
10,136
1,770
38,480
7,063
593
Net Change in Cash
6,889
3,572
1,725
211
32,423
Free Cash Flow
12,255
4,788
2,437
962
40,412
Other Sources
27
-
165
-
-
Change in Capital Stock
2,032
1,144
58,674
7,063
593
Exchange Rate Effect
61
11
15
1
256

About HanAll Biopharma Co.

View Profile
Address
43 Sangseodang 1-gil
Daejeon DE 34344
Korea, Republic Of
Employees -
Website http://www.hanall.co.kr
Updated 07/08/2019
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceutical. Its products include medicine for digesting, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.